Codex points out a problem. Claude Code agrees.
Okay, but show me what breaks. Give me the input, the wrong output, or a failing test.
That's how I'd judge whether the second subscription is doing anything useful.
I Paid $200 a Month for "Max 20x." Anthropic Just Renamed It — and Kept the Smaller Limit
Let me start with who I am: not a reviewer, not a competitor, not a hater on a free account. I'm a paying customer. For months, I paid $200 a month for Claude Max — the top tier, the one called "20x."
Twenty times. That was the product name. That was the promise.
Here's what "20x" actually meant, as Anthropic's own subscription lead explained once users started asking questions: the 20x applied to the 5-hour usage limit. The weekly limit — the one that actually decides how much a heavy user can get done — was 10x.
Read that again. Half the headline number, on the limit that matters more.
When a company discovers its plan's name promises double what the plan delivers, there are two honest options: raise the limit to match the name, or lower the price to match the limit.
Anthropic chose a third option: change the name.
"Max 20x" is now "Ultra." The 20x framing is gone from the label. The 10x weekly limit is still in the product. They removed the number they couldn't defend and kept the limit they didn't want to raise.
That's not fixing a naming confusion. That's selective math. A rename is not a refund, and a new label is not more usage.
Why should you care if you don't pay for Claude? Because this is now the standard playbook for AI subscriptions: sell a multiplier, define that multiplier where it matters least, and when customers notice — rebrand. If renaming counts as fixing, every plan name in this industry is just a rumor.
I'm still a customer. I still think Claude is a great product. That's exactly why this stings — great products don't need creative accounting.
So to the person who signed off on this: you didn't rename my plan. You halved the promise and hoped nobody would do the math.
My advice: resign.
OpenAI wanted $30B. It got ~$11B in commitments, cut the target to $20B, and saw its valuation slide from $1.4T to $1.25T. Even Anthropic is reportedly expected to land only a BB rating pre-IPO. The era of blind AI money is over — or is this just valuations coming back to Earth?